Stockscreener 앱 받기
12.46
1.96%
0.1997
전일 마감가:
$12.26
열려 있는:
$12.38
하루 거래량:
139.41K
Relative Volume:
0.50
시가총액:
$232.17M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-15.57
EPS:
-0.8
순현금흐름:
$153.00K
1주 성능:
+0.16%
1개월 성능:
-11.41%
6개월 성능:
-4.73%
1년 성능:
+139.92%
1일 변동 폭
$11.75
$12.54
1주일 범위
$11.75
$12.58
52주 변동 폭
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
OPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
12.46 | 228.53M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
220.40 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
61.38 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.82 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.94 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.11 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
Head to Head Comparison: Manhattan Associates (NASDAQ:MANH) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) Insider Sells $18,751.88 in Stock - MarketBeat
OptimizeRx CFO sells $18,751 in shares By Investing.com - Investing.com Nigeria
OptimizeRx CFO sells $18,751 in shares - Investing.com
OptimizeRx Corp Executive Sells Shares - TradingView — Track All Markets
How OptimizeRx Corporation stock responds to policy changesMarket Rally & Stepwise Trade Signal Implementation - Улправда
Is OptimizeRx Corporation stock oversold or undervaluedRecession Risk & AI Forecast for Swing Trade Picks - Улправда
Is OptimizeRx Corporation stock a good choice for value investors2025 EndofYear Setup & High Accuracy Investment Signals - DonanımHaber
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Hold” at Zacks Research - Defense World
OptimizeRx (NASDAQ:OPRX) Cut to "Hold" at Zacks Research - MarketBeat
OPRX FinancialsIncome Statement - Quiver Quantitative
OptimizeRx Corp. Expands Point-of-Care Network with Four New Partner Agreements - Quiver Quantitative
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network - The Manila Times
New partnerships plug drug makers into more doctors’ EHR workflows - Stock Titan
Officer D'Silva Surrenders 868 Of OptimizeRx Corp [OPRX] - TradingView — Track All Markets
OptimizeRx Corp (OPRX) insider has 868 shares withheld for taxes - Stock Titan
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to “Strong-Buy” - Defense World
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to "Strong-Buy" - MarketBeat
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Cut to "Buy" at Wall Street Zen - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Buy” at Wall Street Zen - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
Financial Comparison: OptimizeRx (NASDAQ:OPRX) and SS&C Technologies (NASDAQ:SSNC) - Defense World
OptimizeRx Corporation (OPRX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How Recent Developments Are Shaping the OptimizeRx Investment Story - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
OptimizeRx Corporation's (NASDAQ:OPRX) 33% Share Price Plunge Could Signal Some Risk - simplywall.st
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - MarketBeat
Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat
Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com
Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
OptimizeRx CorporationCommon Stock (NQ: OPRX - Markets Financial Content
Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat
OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener
How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
OptimizeRx (OPRX) Analyst Rating Update: Stephens & Co. Lowers P - GuruFocus
Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX - MarketBeat
When is the best time to exit OptimizeRx Corporation2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Published on: 2025-11-16 12:30:34 - newser.com
Will OptimizeRx Corporation stock maintain momentum in 20252025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Brendan W. Merrell Net Worth (2025) - GuruFocus
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Optimizerx Corp 주식 (OPRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward | Chief Finance & Strat Officer |
Dec 19 '25 |
Sale |
13.51 |
1,388 |
18,752 |
126,830 |
| Silvestro Stephen L | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
195,462 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
3,928 |
0 |
94,526 |
| Besch Doug | Chief Product & Tech Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
1,964 |
0 |
71,536 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
92,550 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
3.59%
0.89%
자본화:
|
볼륨(24시간):